OR WAIT null SECS
March 18, 2022
Sanofi is collaborating with Blackstone Life Sciences to accelerate the development of a treatment for multiple myeloma.
March 16, 2022
EMA has recommended that possible side effects of Spikevax and Janssen COVID-19 vaccines be added to product information.
NIH has launched one of the first Phase 1 clinical trials to examine mRNA technology for HIV.
March 10, 2022
Novo Nordisk will expand its existing research collaboration in novel delivery technologies with MIT and Brigham and Women’s Hospital.
Evonik has launched new EUDRATEC technology to improve solubility and performance of oral small molecules.
March 08, 2022
Johnson & Johnson have announced a landmark agreement to enable the manufacturing and availability of its COVID-19 vaccine in Africa by an African company.
Moderna has announced that it has entered a Memorandum of Understanding with the government of the Republic of Kenya to establish its first mRNA manufacturing facility in Africa.
March 04, 2022
Evonik has increased its global supply of plant-derived cholesterol used for mRNA vaccines and gene therapies.
March 03, 2022
A consortium of nine development partners will support Biovac's expansion of its existing vaccine manufacturing plant capacity, while Biovac itself aims to raise funds to boost increased vaccine manufacturing capacity across Africa.
TFF Pharmaceuticals and Catalent will collaborate to develop TFF's platform for manufacturing dry powder particles.